Analysts Have Made A Financial Statement On Optomed Oyj's (HEL:OPTOMED) Second-Quarter Report
Aug 10
Have your own idea? Try our Stock Screener
Finnish (OMX) Healthcare Sector Analysis
UpdatedAug 11, 2025
DataAggregated Company Financials
Companies13
- 7D-5.9%
- 3M10.8%
- 1Y32.1%
- YTD32.3%
Over the last 7 days, the Healthcare industry has dropped 5.9%, driven by a pullback from Orion Oyj of 7.0%. In the past year, the industry has gained 32%. Looking forward, earnings are forecast to grow by 16% annually.
Sector Valuation and Performance
Has the Finnish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 12 Aug 2025 | €12.4b | €5.7b | €426.3m | 19.3x | 29.1x | 2.2x |
| Thu, 10 Jul 2025 | €12.7b | €5.5b | €392.7m | 18.3x | 32.4x | 2.3x |
| Sat, 07 Jun 2025 | €12.2b | €5.5b | €392.7m | 18.6x | 31.1x | 2.2x |
| Mon, 05 May 2025 | €11.4b | €5.5b | €391.6m | 19.1x | 29.1x | 2.1x |
| Wed, 02 Apr 2025 | €11.1b | €5.4b | €364.7m | 20.2x | 30.5x | 2x |
| Fri, 28 Feb 2025 | €10.9b | €5.4b | €370.9m | 20.2x | 29.3x | 2x |
| Sun, 26 Jan 2025 | €10.5b | €5.2b | €274.3m | 24.9x | 38.2x | 2x |
| Tue, 24 Dec 2024 | €9.0b | €5.2b | €274.3m | 19.8x | 32.9x | 1.7x |
| Thu, 21 Nov 2024 | €9.3b | €5.2b | €274.3m | 20.2x | 33.9x | 1.8x |
| Sat, 19 Oct 2024 | €10.0b | €5.0b | €144.2m | 25.4x | 69.2x | 2x |
| Mon, 16 Sep 2024 | €9.8b | €5.0b | €143.6m | 24.6x | 68.3x | 2x |
| Wed, 14 Aug 2024 | €9.4b | €5.0b | €141.7m | 26.6x | 66.3x | 1.9x |
| Fri, 12 Jul 2024 | €8.9b | €4.9b | €115.7m | 27.4x | 76.5x | 1.8x |
| Sun, 09 Jun 2024 | €8.5b | €4.9b | €115.7m | 28.5x | 73.2x | 1.7x |
| Tue, 07 May 2024 | €7.9b | €4.9b | €118.1m | 27.3x | 67x | 1.6x |
| Thu, 04 Apr 2024 | €7.3b | €4.8b | €108.0m | 30.8x | 67.6x | 1.5x |
| Sat, 02 Mar 2024 | €7.7b | €4.8b | €107.9m | 27.7x | 71.5x | 1.6x |
| Mon, 29 Jan 2024 | €8.7b | €4.8b | €135.4m | 33.6x | 64.5x | 1.8x |
| Wed, 27 Dec 2023 | €8.1b | €4.8b | €135.4m | 31.8x | 59.6x | 1.7x |
| Fri, 24 Nov 2023 | €7.6b | €4.8b | €135.4m | 30.1x | 56.4x | 1.6x |
| Sun, 22 Oct 2023 | €7.5b | €5.0b | €270.4m | 27.2x | 27.9x | 1.5x |
| Tue, 19 Sep 2023 | €7.6b | €5.0b | €269.6m | 27.7x | 28.2x | 1.5x |
| Thu, 17 Aug 2023 | €7.3b | €5.0b | €276.3m | 23.3x | 26.5x | 1.5x |
| Sat, 15 Jul 2023 | €8.0b | €5.0b | €315.2m | 38.7x | 25.3x | 1.6x |
| Mon, 12 Jun 2023 | €8.7b | €5.0b | €315.2m | 40.1x | 27.5x | 1.7x |
| Wed, 10 May 2023 | €9.1b | €5.0b | €314.4m | 43.6x | 28.8x | 1.8x |
| Fri, 07 Apr 2023 | €9.1b | €5.0b | €343.2m | 38x | 26.6x | 1.8x |
| Sun, 05 Mar 2023 | €9.3b | €5.0b | €332.6m | 37.8x | 27.9x | 1.9x |
| Tue, 31 Jan 2023 | €10.1b | €5.3b | €373.8m | 19.7x | 26.9x | 1.9x |
| Thu, 29 Dec 2022 | €10.3b | €5.3b | €373.8m | 18x | 27.6x | 1.9x |
| Sat, 26 Nov 2022 | €9.9b | €5.3b | €384.8m | 18.9x | 25.8x | 1.9x |
| Mon, 24 Oct 2022 | €8.9b | €5.3b | €421.5m | 16.9x | 21.2x | 1.7x |
| Wed, 21 Sep 2022 | €9.4b | €5.0b | €284.2m | 18.3x | 33.2x | 1.9x |
| Fri, 19 Aug 2022 | €10.5b | €5.0b | €291.7m | 19.5x | 35.9x | 2.1x |
Price to Earnings Ratio
35.9x
Current Industry PE
- Investors are pessimistic on the Finnish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 29.1x which is lower than its 3-year average PE of 42.2x.
- The 3-year average PS ratio of 1.8x is lower than the industry's current PS ratio of 2.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 13% per year over the last three years.
- Revenues for these companies have grown 4.0% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare sector?
| FI Market | 2.23% | |
| Healthcare | -5.92% | |
| Healthtech | 0.30% | |
| Biotech | 0% | 0 |
| Healthcare Services | -1.37% | |
| Medical Equipment | -5.41% | |
| Pharma | -6.97% | |
| Life Sciences | -8.65% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 224x.
- Analysts are expecting annual earnings growth of 28.3%, which is higher than its past year's earnings growth of 15.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 49% over the next 5 years.
- In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NXTMH Nexstim | €14.95 | 6.4% +€6.5m | 435.8% | PS10.5x | |
| HRTIS Herantis Pharma Oyj | €1.95 | 3.2% +€1.4m | 37.8% | PE-9.5x | |
| MODU Modulight Oyj | €1.22 | 1.3% +€679.8k | 3.9% | PS6.4x | |
| BRETEC Bioretec Oy | €1.84 | 1.1% +€615.7k | -35.4% | n/a |
